Inventor
BAETTIG URS
GB20 patents
⚠️ This page may combine multiple inventors who share the name “BAETTIG URS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
10 patentsUS7989497B2Aug 2, 2011
Squaramide derivatives as CXCR2 antagonist
NOVARTIS AG13 citations91
US7947730B2May 24, 2011
Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
NOVARTIS AG7 citations84
US9365552B2Jun 14, 2016
Pyridine and pyrazine derivative for the treatment of CF
NOVARTIS AG5 citations82
US10117858B2Nov 6, 2018
Pyridine and pyrazine derivative for the treatment of CF
NOVARTIS AG2 citations71
US8343966B2Jan 1, 2013
Organic compounds
NOVARTIS AG6 citations71
US11911371B2Feb 27, 2024
Pyridine and pyrazine derivative for the treatment of chronic bronchitis
NOVARTIS AG0 citations61
USRE46757EMar 20, 2018
Pyridine and pyrazine derivative for the treatment of CF
NOVARTIS AG1 citations61
US7723356B2May 25, 2010
Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
NOVARTIS AG3 citations60
US10183025B2Jan 22, 2019
Autotaxin inhibitors
NOVARTIS AG0 citations47
US9763957B2Sep 19, 2017
Autotaxin inhibitors
NOVARTIS AG1 citations47
BAETTIG URS
6 patentsUS8247436B2Aug 21, 2012
Pyridine and pyrazine derivative for the treatment of CF
BAETTIG URS87 citations96
US8722925B2May 13, 2014
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS13 citations91
US9115087B2Aug 25, 2015
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS11 citations82
US8476269B2Jul 2, 2013
Pyridine and pyrazine derivative for the treatment of CF
BAETTIG URS7 citations82
US8329754B2Dec 11, 2012
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS11 citations82
US8288588B2Oct 16, 2012
Squaramide derivatives as CXCR2 antagonist
BAETTIG URS11 citations82